Bernard N. Kanoi

Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36

Nirianne Palacpac, Edward Hosea Ntege, Adoke Yeka et al. · PLoS ONE · 2013 · 70 citations · Full text

Continuing Intense Malaria Transmission in Northern Uganda

Carla Proietti, Davide D. Pettinato, Bernard N. Kanoi et al. · American Journal of Tropical Medicine and Hygiene · 2011 · 62 citations · Full text

Vaccination, Northern Uganda, Global Health +13

Naturally acquired antibody responses to more than 300 Plasmodium vivax proteins in three geographic regions

Rhea J. Longley, Michael White, Eizo Takashima et al. · PLoS neglected tropical diseases · 2017 · 59 citations · Full text

Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda

Bernard N. Kanoi, Eizo Takashima, Masayuki Morita et al. · Vaccine · 2017 · 49 citations

Malaria, Immunology, Antibody Profiles +6

Influence of infection on malaria‐specific antibody dynamics in a cohort exposed to intense malaria transmission in northern <scp>U</scp>ganda

Carla Proietti, Federica Verra, M. Bretscher et al. · Parasite Immunology · 2013 · 46 citations